Published January 26, 2024 | Version v1
Journal article Open

EPAS1/HIF2A missense variant is associated with hematocrit in Andean highlanders

  • 1. ROR icon University of California, San Francisco

Description

Hypoxia inducible factor pathway genes are linked to adaptation in both human and non-human highland species. EPAS1, a notable target of hypoxia adaptation, is associated with relatively lower hemoglobin concentration in Tibetans. We provide evidence for an association between an adaptive EPAS1 variant (rs570553380) and the same phenotype of relatively low hematocrit in Andean highlanders. This Andean-specific missense variant is present at a modest frequency in Andeans and absent in other human populations and vertebrate species except the coelacanth. CRISPR-base-edited human cells with this variant exhibit shifts in hypoxia-regulated gene expression, while metabolomic analyses reveal both genotype and phenotype associations and validation in a lowland population. Although this genocopy of relatively lower hematocrit in Andean highlanders parallels well-replicated findings in Tibetans, it likely involves distinct pathway responses based on a protein-coding versus non-coding variants, respectively. These findings illuminate how unique variants at EPAS1 contribute to the same phenotype in Tibetans and a subset of Andean highlanders despite distinct evolutionary trajectories.

Files

CRISPR Transcriptomics.zip

Files (196.4 MB)

Name Size Download all
md5:df3d31c37eb436e85c218cb7767f4be3
11.7 kB Preview Download
md5:d27a5af0c29ea460351d83582d26119e
1.3 kB Preview Download
md5:fa69cb42494c43098fa9782b1ae4fa2c
89.4 kB Preview Download
md5:817ea44d9ef0ad2f33eed36ad8583413
2.7 MB Preview Download
md5:1ce84e04929f05870dddf188c1f39e1c
58.8 kB Preview Download
md5:50499fc06d14323304282e43e91d7393
4.6 kB Preview Download
md5:20864f8a20ca4fcdceabfd574f0818a3
2.0 kB Preview Download
md5:e723a9d9781fc83ae5ace644a75ebb0c
193.5 MB Preview Download
md5:0a2da41d2bd1e4668945a7e411091818
9.6 kB Preview Download

Additional details

Dates

Accepted
2024-01-26